New TNF-α releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen
Hirota Fujiki(National Cancer Centre Japan), Takashi Yoshida(Shizuoka City Shimizu Hospital), Miki Kurusu(Saitama Cancer Center), Masami Suganuma(Saitama University), Yoko Imayoshi(Okayama University), Shoko Taniguchi(Okayama University), Sachiko Okabe(Saitama Cancer Center)
Mutation research. Fundamental and molecular mechanisms of mutagenesis
February 1, 2003
Cited by 79
Related Papers
Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR
|Journal of Cancer Research and Clinical Oncology|1992|807
Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.
|Proceedings of the National Academy of Sciences|1988|602
Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention
|BioFactors|2000|408
Tumor Promotion by Inhibitors of ProteinZ Phosphatases 1 and 2A: The Okadaic Acid Class of Compounds
|Advances in cancer research|1993|310
Production of bioactive triterpenes by Eriobotrya japonica calli
|Phytochemistry|2002|292